医療薬学
Online ISSN : 1882-1499
Print ISSN : 1346-342X
ISSN-L : 1346-342X
ノート
高齢者におけるカンデサルタン8 mgからカンデサルタン8 mg/ヒドロクロロチアジド6.25 mg配合錠への切り替えによる有効性と安全性の検討
高井 靖木本 珠美梶間 勇樹西川 英郎大井 一弥
著者情報
ジャーナル フリー

2014 年 40 巻 9 号 p. 537-541

詳細
抄録

In patients in whom an angiotensin receptor blocker was switched to tablets containing an ARB, candesartan, at 8 mg and a diuretic, hydrochlorothiazide, at 6.25 mg (ECARD® HD tablets), efficacy and safety were examined. Of the 38 patients analyzed for efficacy assessment, 24 aged 65 years or older were assigned to an elderly group, and 14 aged 64 years or younger to a non-elderly group. The results were compared between the two groups. There were significant decreases in the systolic and diastolic blood pressures in the two groups (P < 0.05). In the elderly group, the blood pressure gradually reduced. In this group, there was a significant decrease in the heart rate (P < 0.05). There were no significant changes in the serum creatinine or potassium levels in either group. There was a significant increase in the uric acid level in the elderly group (P < 0.05). These results suggest that switching of an ARB to ECARD® HD tablets is an option for blood pressure control in elderly people. However, the monitoring of the heart rate, the serum creatinine, and the uric acid is required.

著者関連情報
© 2014 日本医療薬学会
前の記事
feedback
Top